SOMMAGGIO, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 1.887
AS - Asia 260
EU - Europa 212
OC - Oceania 4
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.366
Nazione #
US - Stati Uniti d'America 1.882
CN - Cina 133
IT - Italia 108
SG - Singapore 89
FI - Finlandia 29
VN - Vietnam 22
SE - Svezia 18
DE - Germania 17
FR - Francia 16
GB - Regno Unito 11
HK - Hong Kong 6
AU - Australia 4
CA - Canada 4
UA - Ucraina 4
IN - India 3
BD - Bangladesh 2
IE - Irlanda 2
JP - Giappone 2
NL - Olanda 2
RU - Federazione Russa 2
AR - Argentina 1
BR - Brasile 1
ES - Italia 1
EU - Europa 1
GT - Guatemala 1
IR - Iran 1
KR - Corea 1
PL - Polonia 1
RO - Romania 1
TW - Taiwan 1
Totale 2.366
Città #
Fairfield 334
Chandler 194
Woodbridge 163
Ashburn 162
Houston 153
Ann Arbor 131
Seattle 126
Cambridge 122
Wilmington 102
Singapore 72
Padova 57
Boardman 50
San Diego 35
Beijing 28
Medford 23
Princeton 23
Dong Ket 22
Nanjing 17
Santa Clara 17
Des Moines 13
Helsinki 13
Duncan 9
Rome 9
Dearborn 7
Roxbury 7
Shenyang 7
Hebei 6
Hong Kong 6
Nanchang 6
Ogden 6
Changsha 5
Jiaxing 5
Los Angeles 5
Ningbo 5
Cesiomaggiore 4
Coral Gables 4
Jinan 4
Kharkiv 4
London 4
Milan 4
Norwalk 4
Trieste 4
Zhengzhou 4
Albignasego 3
Haikou 3
New York 3
Selvazzano Dentro 3
Venice 3
Washington 3
Berlin 2
Borås 2
Brisbane 2
Chengdu 2
Chongqing 2
Dublin 2
Guangzhou 2
Indiana 2
Kiel 2
Kunming 2
Las Vegas 2
Noventa Vicentina 2
Raipur 2
Rockville 2
Shanghai 2
Taizhou 2
Tivoli 2
Amsterdam 1
Breganze 1
Brentford 1
Centro 1
Chicago 1
Dallas 1
Edinburgh 1
Frankfurt am Main 1
Glasgow 1
Hangzhou 1
Hefei 1
Kilburn 1
Lappeenranta 1
Legnaro 1
Melbourne 1
Montecchio Precalcino 1
Montreal 1
Munich 1
Okotoks 1
Pordenone 1
Pozzo 1
Pune 1
Qingdao 1
San Francisco 1
San Jose 1
Savignano sul Panaro 1
Somma Vesuviana 1
Sommacampagna 1
St Petersburg 1
Stockholm 1
Sydney 1
São Paulo 1
Taipei 1
Taiyuan 1
Totale 2.062
Nome #
Enhanced EGFR Targeting Activity of Plasmonic Nanostructures with Engineered GE11 Peptide 179
A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors 149
The mitochondrial calcium uniporter regulates breast cancer progression via HIF-1α 126
Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells 126
Metabolic control of YAP and TAZ by the mevalonate pathway. 118
Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells 118
Midgut carcinoid patients display increased numbers of regulatory T cells in peripheral blood with infiltration into tumor tissue. 103
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks 98
Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development 95
Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1 95
Mutant p53 Reprograms TNF Signaling in Cancer Cells through Interaction with the Tumor Suppressor DAB2IP. 93
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer 93
TNF, pig CD86, and VCAM-1 identified as potential targets for intervention in xenotransplantation of pig chondrocytes. 90
Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies 88
SYNTHESIS AND BIOFUNCTIONALIZATION OF PLASMONIC NANOSTRUCTURES FOR EGFR-MARKED CANCER CELL TARGETING AND SERRS IMAGING 88
Inhibition of complement component C5 protects porcine chondrocytes from xenogeneic rejection. 86
An HMGA1 Specific Transcriptional Program Promotes Metastasis in Breast Cancer 84
CD8+ T cells against multiple tumor-associated antigens in peripheral blood of midgut carcinoid patients. 84
HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness 82
Multiple receptors trigger human NK cell-mediated cytotoxicity against porcine chondrocytes. 76
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells 70
Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast 68
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome 63
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report 34
Cell-Based Assays for Modeling Xenogeneic Immune Responses 27
Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy 16
How can Cytokine-induced killer cells overcome CAR-T cell limits 14
Cellular studies for in vitro modeling of xenogeneic immune responses. 13
Genetic engineering strategies to prevent the effects of antibody and complement on xenogeneic chondrocytes 8
Xenotransplantation of Pig chondrocytes: Therapeutic potential and barriers for cartilage repair 7
Cellular studies for in vitro modeling of xenogeneic immune responses 7
Totale 2.398
Categoria #
all - tutte 9.306
article - articoli 8.636
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 313
Totale 18.255


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020342 0 0 0 0 45 34 49 53 46 75 31 9
2020/2021428 19 19 33 27 11 9 23 19 47 96 41 84
2021/2022424 52 54 51 24 25 19 24 43 12 16 25 79
2022/2023335 58 56 10 61 45 31 7 17 29 1 18 2
2023/2024179 6 18 15 10 17 20 19 13 8 5 22 26
2024/2025207 6 69 27 25 80 0 0 0 0 0 0 0
Totale 2.398